Studies related to Reaction Time and Ginkgo biloba

A double-blind placebo-controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly
Effect Increase
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 54
Sex Both Genders
Age Range 65+
Notes for this study:
Supplementation of EGb-761 daily over the course of 3 months in elderly persons experiencing cognitive decline but not diagnosed with dementia or other neurodegenerative diseases noted improvements in cognition and reaction time relative to placebo.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.